| ¿µ¹® | hyperthermia, fever | ÇÑ±Û | °í¿ |
|---|---|---|---|
| ¼³¸í | ü¿ÂÁ¶Àý ÁßÃß°¡ ÀÌ»óÀ» ÃÊ·¡ÇØ Ã¼¿ÂÀÌ °è¼Ó »ó½ÂÇÏ¿© Áö¼ÓµÇ°í ÀÖ´Â »óŸ¦ ¸»ÇÑ´Ù. ¿øÀÎÀº ´Ù¾çÇϸç ü¿ÂÁ¶Àý ÁßÃßÀÇ Àå¾Ö(³úÁúȯ), Á¶Á÷Àå¾Ö¿¡ ÀÇÇÑ °ÍÀÌ ÀÖ´Ù. ü¿ÂÀº ÀϹÝÀûÀ¸·Î °Üµå¶ûÀÌ, ÀÔ¾È, °ðâÀÚ¿¡¼ Àç°í, ½Ã°£Àº 10ºÐÀ» ÇÊ¿ä·Î ÇÑ´Ù. Åë»ó 37¡É ÀÌÇÏ(°Üµå¶ûÀÌ)·Î, ÀÔ¾È ¿Âµµ´Â À̺¸´Ù 0.1~0.2¡É ³ôÀ¸¸ç, °ðâÀڿµµ´Â 0.2~0.5¡É ³ô´Ù. °íü¿ÂÁõ¿¡¼µµ µ¿°á°ú À¯»çÇÑ ¼¼Æ÷ º¯È°¡ ³ªÅ¸³´Ù. Áï Ç÷°ü³»ÇǼ¼Æ÷¿¡ ¼Õ»óÀÌ »ý±â°í Ç÷°üÅõ°ú°¡ Áõ°¡µÇ¾î ºÎÁ¾, ¼öÆ÷ µîÀÌ Çü¼ºµÈ´Ù. |
||
| ¿µ¹® | dengue fever | ÇÑ±Û | µ±â |
|---|---|---|---|
| ¼³¸í | ÁÖ·Î ¿´ëÁö¹æ¿¡¼ ¹ß»ýÇÏ´Â ¹ÙÀÌ·¯½º¼º ¿º´. 4~8ÀÏÀÇ Àẹ±â¸¦ °ÅÃÄ ±Þ°ÝÇÏ°Ô ¹ß¿Çϰí, °á¸·ÃæÇ÷-°üÀýÅë-±ÙÀ°Åë-¹éÇ÷±¸°¨¼Ò µîÀÇ Áõ»óÀ» º¸ÀδÙ. ´ëºÎºÐ 7~10ÀÏ ÈÄ¿¡´Â ȸº¹µÇ¸ç, »ç¸ÁÇÏ´Â ¿¹´Â µå¹°´Ù. ¹Ì±¹ÀÇ ¼¼±ÕÇÐÀÚÀÎ C.F. Å©·¹À̱״ 1907³â Çʸ®ÇÉ¿¡¼ µ±â¿Àº ¸ð±â¿¡ ÀÇÇØ °¨¿°µÈ´Ù´Â °ÍÀ» È®ÀÎ-º¸°íÇß´Ù. Á¦2Â÷ ¼¼°è´ëÀü Á÷ÈÄ ¹Ì±¹ÀÇ ¼¼±ÕÇÐÀÚ A. B. ¼¼À̺óÀº ±×ÀÇ ¿¬±¸¿¡ ÀÇÇØ µ±â¿ ¹ÙÀÌ·¯½º¿¡´Â ¸é¿ªÇÐÀûÀ¸·Î ³×°¡Áö ÇüÀÌ ÀÖ´Ù°í ¹àÇû´Ù. µ±â¿ ¹ÙÀÌ·¯½º¸¦ ¸Å°³ÇÏ´Â ¸ð±â¿¡´Â ÀÌÁýÆ®½£¸ð±â(Aedes aegypti)¿Í ÈòÁÙ½£¸ð±â(Aedes albopictus)°¡ ¾Ë·ÁÁ® ÀÖ´Ù. ÀÌ º´¿¡ °É¸®°í ³ª¸é ¸é¿ªÀÌ »ý±âÁö¸¸ Áö¼Ó±â°£Àº ºñ±³Àû ª´Ù. |
||
| ¿µ¹® | typhus fever | ÇÑ±Û | ¹ßÁøÆ¼Çª½º |
|---|---|---|---|
| ¼³¸í | °í¿°ú ¹ßÁøÀÌ ÁÖÁõ¼¼ÀÎ ¿¼º-±Þ¼ºÀÇ ¹ýÁ¤Àü¿°º´. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ º¸°Ç±ÔÄ¢¿¡ ÀÇÇÑ ±¹Á¦ °¨½Ã Àü¿°º´ÀÇ ÇϳªÀ̱⵵ ÇÏ´Ù. ¶ÇÇÑ, ÀÌ º´ÀÇ À¯ÇàÀº ÀüÀï°ú °ü°è°¡ ±í¾î ÀüÀïÆ¼Çª½º ¶Ç´Â ±â±Ù¿-±³µµ¼Ò¿ µîÀÇ º°¸íÀÌ ÀÖ´Ù. ±×°ÍÀº ÀÌ º´ÀÇ ¸Å°³°ïÃæÀÎ ¡®¿ÊÀÌ¡¯°¡ ÀÇ·ù³ª ¸öÀÌ ´õ·¯¿ï ¶§ ¹ß»ýÇϱ⠽¬¿ì¹Ç·Î ±º´ë³ª ±³µµ¼Ò, ÀüÀïÅÍ µî ȯ°æÀÌ ³ª»Û °÷¿¡¼ Å©°Ô À¯ÇàÇÏ°Ô µÇ¾ú±â ¶§¹®À̾ú´Ù. Á¦1Â÷ ¼¼°è´ëÀü ´ç½Ã ·¯½Ã¾Æ¿¡¼ ¹ß»ýÇÑ È¯ÀÚÀÇ ¼ö´Â 2,500¸¸ ¸íÀ̳ª µÇ¾ú°í, ¿µ±¹°ú ±âŸ À¯·´¿¡¼µµ ÀüÀï-±â±Ù ¶§¹®¿¡ ÀÌ º´ÀÌ ´ëÀ¯ÇàÇß´ø ±â·ÏÀÌ ÀÖÀ¸¸ç, ÀϺ»¿¡¼µµ Á¦2Â÷ ¼¼°è´ëÀü Á÷ÈÄ¿¡ À¯Çà Çß¾ú´Ù. ¿À´Ã³¯¿¡´Â ¾ÆÇÁ¸®Ä«-À¯·´-¾Æ½Ã¾ÆÀÇ ÀϺÎÁö¿ª¿¡¸¸ Á¸ÀçÇÒ »ÓÀÌ´Ù. º´¿øÃ¼´Â ¸®ÄÉÂ÷ ÇÁ·Î¹ÙÁ¦Å°(Rickettsia prowazeki)·Î ¿ÊÀÌ¿¡ ±â»ýÁõ½ÄÇÏ¿© ¿ÊÀÌÀÇ ºÐº¯°ú ÇÔ²² ¹è¼³µÇ¸é¼ ¿ÊÀ̰¡ ÈíÇ÷Çϱâ À§ÇØ ÇǺο¡ ÁØ »óó³ª »ç¶÷ÀÌ ¼ÕÀ¸·Î ±Ü¾î »ý±ä »óó¸¦ ÅëÇÏ¿© °¨¿°µÈ´Ù. Àẹ±â°£Àº 10~14ÀÏÀÌ¸ç ±ÞÀÛ½º·± ¿ÀÇÑÀ̳ª ÇÔ²² ¹ß¿ÇÏ¿© 3ÀÏ Á¤µµ °æ°úµÇ¸é 40¡É ÀüÈÄÀÇ °í¿ÀÌ ³ª°Ô µÇ°í, µÎÅë-°üÀýÅë-°á¸·ÃæÇ÷ µî°ú Áö¸§ 2mm ¾ÈÆÆÀÇ ºÓ°í ÀÛÀº ÃâÇ÷¼º ¹ßÁøÀÌ ¿Â¸ö¿¡ ¸¹ÀÌ »ý±ä´Ù. Áõ¼¼´Â ÀåÆ¼Çª½º¿Í ºñ½ÁÇϰí, ¹ÙÀÏ-Æç¸¯½º¹ÝÀÀ(Weil-Felix test)À̶ó ÇÏ´Â Ç÷û¹ÝÀÀ¿¡ ÀÇÇØ °¨º°µÈ´Ù. Ŭ·Î¶÷Æä´ÏÄÝÀ̳ª Åׯ®¶ó»çÀÌŬ¸°°èÀÇ Ç×»ý¹°ÁúÀÌ Æ¯È¿¸¦ º¸¿© Ä¡»çÀ²µµ ³·¾ÆÁ³´Ù(20%). ¿¹¹æÀ¸·Î´Â »ìÃæÁ¦·Î ¿ÊÀ̸¦ ±¸Á¦ÇÏ´Â °ÍÀÌ °¡Àå Áß¿äÇϸç, ¹ßÁøÆ¼Çª½º¹é½Å Á¢Á¾µµ À¯È¿ÇÏ´Ù. |
||
| ¿µ¹® | scarlet fever | ÇÑ±Û | ¼ºÈ«¿ |
|---|---|---|---|
| ¼³¸í | AÇü¿ëÇ÷»ç½½¾Ë±Õ¿¡ ÀÇÇÑ ¹ýÁ¤ ±Þ¼ºÀü¿°º´ÀÌ´Ù. 5~10¼¼ÀÇ ¼Ò¾Æ¿¡¼ È£¹ßÇÑ´Ù. ÀÛÀº ħ¹æ¿ïÀ» ÅëÇÏ¿© °¨¿°µÇ¸ç Àẹ±âÀÎ 2~4ÀÏÀ» Áö³ª, ÃʱâÁõ»óÀº °í¿, ÀεÎÁ¡¸·, Æíµµ°¡ ÇöÀúÇÏ°Ô ¹ßÀûÁ¾´ëµÈ´Ù. 1~2ÀÏ ÈÄ ºñÀ¶ÇÕ¼ºÀÇ È«»ö¼Ò±¸ÁøÀÌ Àü½Å¿¡ ÃâÇöÇÑ´Ù. ÀÔ ¾ðÀú¸®¿¡´Â ¹ßÁøÀÌ ¾ø°í ÀÔ¼úÁÖÀ§´Â â¹éÇÏ¸ç µþ±âÇô¸¦ º»´Ù. 2~3ÀÏ ÈÄ ¹ßÁøÀÌ »ç¶óÁø´Ù. º´º¯ºÎÀÇ ´ëºÎºÐÀº Ç¥ÃþÀÌ ¹Ú¸®µÇ´Âµ¥ ƯÈ÷ ¼Õ°ú ¹ßÀÇ À¶ÇÕ¼º Å»Çǰ¡ Ư¡ÀÌ´Ù. ÇöÀç´Â °ú°Å¿¡ ºñÇÏ¿© ÈξÀ º´ÀÌ °¡º¿öÁ®¼ ÁßÀÌ¿°, ¹ÙÀ§, ȳó¸²ÇÁÀý¿°µµ µå¹°´Ù. ÀεÎÁ¡¸·¹è¾çÀ¸·Î ±ÕÀ» Áõ¸íÇÏ¿© Áø´ÜÇÑ´Ù. A±º »ç½½¾Ë±Õ°¨¿°ÀÇ ÇÕº´ÁõÀ¸·Î´Â ¸é¿ªº¹ÇÕü¼ºÄáÆÏ¿°°ú ·ù¸¶Æ¼½º¿ÀÌ µÈ´Ù. |
||
| ¿µ¹® | fever | ÇÑ±Û | ¿ |
|---|---|---|---|
| ¼³¸í | ü¿ÂÁ¶Àý ÁßÃß°¡ ÀÌ»óÀ» ÃÊ·¡ÇØ Ã¼¿ÂÀÌ °è¼Ó »ó½ÂÇÏ¿© Áö¼ÓµÇ°í ÀÖ´Â »óŸ¦ ¸»ÇÑ´Ù. ¿øÀÎÀº ´Ù¾çÇϸç ü¿ÂÁ¶Àý ÁßÃß¿¡ Àå¾Ö(³úÁúȯ), Á¶Á÷ Àå¾Ö¿¡ ÀÇÇÑ °ÍÀÌ ÀÖ´Ù. ü¿ÂÀº ÀϹÝÀûÀ¸·Î °Üµå¶ûÀÌ, ÀÔ¾È, °ðâÀÚ¿¡¼ Àç°í, ½Ã°£Àº 10ºÐÀ» ÇÊ¿ä·Î ÇÑ´Ù. Åë»ó 37¡ÉÀÌÇÏ(°Üµå¶ûÀÌ)·Î, ÀÔ¾È ¿Âµµ´Â À̺¸´Ù 0.1~0.2¡É ³ôÀ¸¸ç, °ðâÀڿµµ´Â 0.2~0.5¡É ³ô´Ù. |
||
| HFRS | Hemorrhagic Fever with Renal Syndrome [HP 849-50] = Korean Hemorrhagic Fever &nbs... |
|---|---|
| YFI | yellow fever immunization |
| CON | certificate of need |
| N-P | need-persistence |
| YF | yellow fever |
| YF | Yellow Fever |
|---|---|
| YF | Yellow Fever virus |
| YFV | Yellow Fever virus |
| CON | Certificate of Need |
| CII | Childhood Immunization Initiative |
| astigmatism against the rule | Astigmatism when the greater curvature or refractive power is in the horizontal meridian. (05 Mar 2000) |
|---|---|
| certificate of need | A certificate issued by a governmental body to an individual or organization proposing to construct or modify a health facility, or to offer a new or different service. The process of issuing the certificate is also included. (12 Dec 1998) |
| need | 1. A state that requires supply or relief; pressing occasion for something; necessity; urgent want. "And the city had no need of the sun." (Rev. Xxi. 23) "I have no need to beg." (Shak) "Be governed by your needs, not by your fancy." (Jer. Taylor) 2. Want of the means of subsistence; poverty; indigence; destitution. "Famine is in thy cheeks; Need and oppression starveth in thine eyes." (Shak) 3. That which is needful; anything necessary to be done; (pl) necessary things; business. 4. Situation of need; peril; danger. Synonym: Exigency, emergency, strait, extremity, necessity, distress, destitution, poverty, indigence, want, penury. Need, Necessity. Necessity is stronger than need; it places us under positive compulsion. We are frequently under the necessity of going without that of which we stand very greatly in need. It is also with the corresponding adjectives; necessitous circumstances imply the direct pressure of suffering; needy circumstances, the want of aid or relief. Origin: OE. Need, neod, nede, AS. Nead, n<ymac/d; akin to D. Nood, G. Not, noth, Icel. Nauthr, Sw. & Dan. Nod, Goth. Naups. Source: Websters Dictionary (01 Mar 1998) |
| jungle yellow fever | A form occurring in South America, transmitted by Aedes leucocelaenus and various treetop mosquitoes of the Haemagogus complex; transmitted normally to primates, occasionally by chance to man to set off a human outbreak of classical yellow fever transmitted by Aedes aegypti. (05 Mar 2000) |
| yellow fever | <microbiology> An acute febrile illness of tropical regions, caused by a group B arbovirus and spread by a mosquito (Aedes aegypti). Characteristic features include: jaundice, black vomit and the absence of urination. Vaccination is available for travelers to endemic areas. (27 Sep 1997) |
| yellow fever vaccination | A live attenuated (weakened) viral vaccine recommended for people traveling to or living in tropical areas in the americas and africa where yellow fever occurs. (12 Dec 1998) |
| yellow fever vaccine | A living, attenuated strain (17D) of yellow fever virus propagated in embryonated fowl eggs. A suspension of dried mouse brain infected with French neurotropic (Dakar) strain of yellow fever virus, administered topically by the scratch method; not officially recommended in the United States because of meningoencephalitic reactions. (05 Mar 2000) |
| yellow fever virus | <virology> A togavirus (Class IV) with an RNA genome responsible for the disease of the name whose symptoms include fever and haemorrhage. Transmitted by the mosquitoes Aedes aegypti and Haemagogus. Only one antigenic type of the virus known and causes fatal hepatitis in many primates, including humans. This virus is endemic to areas of Africa, South America and the Carribean and has been a major epidemic threat. (11 May 1997) |
| active immunization | The production of active immunity. (05 Mar 2000) |
| anthrax immunization | A series of six shots over six months and booster shots annually, the anthrax vaccine now in use in the USA was first developed in the 1950s and approved by the Food and Drug Administration for general use in 1970. It is produced by the Michigan Biologic Products Institute of Michigan's Department of Health and is given routinely to veterinarians and others working with livestock. In December, 1997 it was announced that all US military would receive the vaccine, as do the military in the UK and Russia, the reason being concern that anthrax might be used in biologic warfare. (12 Dec 1998) |
| german measles immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (German measles). The MMR vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or MMR vaccination prior to entrance. Most children should receive MMR vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the MMR vaccine. Pregnant women should wait until after delivery before being immunised with MMR. People with HIV or AIDS should normally receive MMR vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| passive immunization | The production of passive immunity. (05 Mar 2000) |
| measles immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| chickenpox immunization | This vaccine prevents the common disease known as chickenpox (varicella zoster). While chickenpox is often considered a trivial illness, it can cause significant lost time on the job and in school and have serious complications including ear infections, pneumonia, and infection of the rash with bacteria, inflammation of the brain (encephalitis) leading to difficulty with balance and coordination (cerebellar ataxia), damaged nerves (palsies), and Reye's syndrome, a potentially fatal complication. The vaccination requires only one shot given at about a year of age. If an older person has not had chickenpox, the shot may be given at any time. There have been few significant reactions to the chickenpox vaccine. All children, except those with a compromised immune system, should have the vaccination. (12 Dec 1998) |
| rubella immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|